• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

计算机断层扫描评估常染色体显性多囊肾病进展:一份进展报告。

Computed tomography evaluation of autosomal dominant polycystic kidney disease progression: a progress report.

作者信息

Antiga Luca, Piccinelli Marina, Fasolini Giorgio, Ene-Iordache Bogdan, Ondei Patrizia, Bruno Simona, Remuzzi Giuseppe, Remuzzi Andrea

机构信息

Biomedical Engineering Department, Mario Negri Institute for Pharmacological Research, Villa Camozzi, 24020 Ranica (BG), Italy.

出版信息

Clin J Am Soc Nephrol. 2006 Jul;1(4):754-60. doi: 10.2215/CJN.02251205. Epub 2006 Jun 14.

DOI:10.2215/CJN.02251205
PMID:17699283
Abstract

At the moment, there are no effective therapies to prevent or slow the progression of autosomal dominant polycystic kidney disease (ADPKD). Radiologic evaluations are used to monitor volume of renal cysts and parenchyma during disease evolution. Volumetric quantifications based on computed tomography were used to investigate the relation between structural and functional changes in patients with advanced-stage ADPKD. By use of image-processing techniques, volume of kidneys, renal cysts, fully enhanced parenchyma, and faintly contrast-enhanced parenchyma, referred to as intermediate, was estimated. GFR measurements and computed tomography evaluations were repeated 6 mo later. No statistically significant correlations were found between volumes of cysts and parenchyma and intermediate volume and GFR. However, the ratio of intermediate over parenchymal volume strongly correlated with GFR (r = -0.81, P < 0.001). In addition, there were significant correlations between percentage changes in intermediate volume (absolute or relative to parenchyma) and GFR changes during the observation period (r = -0.70 and r = -0.75, P < 0.01). These data support the hypothesis of a significant relation between radiologic appearance of renal structure and functional changes and suggest new ways that renal dysfunction in ADPKD may be predicted. Further work is necessary to determine the nature of faintly contrast-enhanced parenchyma and its role in renal functional loss.

摘要

目前,尚无有效的疗法来预防或减缓常染色体显性遗传性多囊肾病(ADPKD)的进展。在疾病进展过程中,放射学评估用于监测肾囊肿和肾实质的体积。基于计算机断层扫描的体积定量分析被用于研究晚期ADPKD患者结构和功能变化之间的关系。通过使用图像处理技术,对肾脏、肾囊肿、完全强化的肾实质以及称为中间部分的轻度强化肾实质的体积进行了估计。6个月后重复进行肾小球滤过率(GFR)测量和计算机断层扫描评估。未发现囊肿和肾实质体积、中间部分体积与GFR之间存在统计学上的显著相关性。然而,中间部分体积与肾实质体积之比与GFR密切相关(r = -0.81,P < 0.001)。此外,在观察期内,中间部分体积的百分比变化(绝对变化或相对于肾实质的相对变化)与GFR变化之间存在显著相关性(r = -0.70和r = -0.75,P < 0.01)。这些数据支持了肾脏结构的放射学表现与功能变化之间存在显著关系的假设,并提示了预测ADPKD肾功能障碍的新方法。有必要进一步开展工作来确定轻度强化肾实质的性质及其在肾功能丧失中的作用。

相似文献

1
Computed tomography evaluation of autosomal dominant polycystic kidney disease progression: a progress report.计算机断层扫描评估常染色体显性多囊肾病进展:一份进展报告。
Clin J Am Soc Nephrol. 2006 Jul;1(4):754-60. doi: 10.2215/CJN.02251205. Epub 2006 Jun 14.
2
Volumetric determination of progression in autosomal dominant polycystic kidney disease by computed tomography.通过计算机断层扫描对常染色体显性遗传性多囊肾病进展进行容积测定
Kidney Int. 2000 Dec;58(6):2492-501. doi: 10.1046/j.1523-1755.2000.00433.x.
3
Quantification and longitudinal trends of kidney, renal cyst, and renal parenchyma volumes in autosomal dominant polycystic kidney disease.常染色体显性多囊肾病中肾脏、肾囊肿及肾实质体积的定量分析与纵向趋势研究
J Am Soc Nephrol. 2000 Aug;11(8):1505-1511. doi: 10.1681/ASN.V1181505.
4
Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.常染色体显性多囊肾病(ADPKD)早期的肾脏结构:多囊肾病放射影像学研究联盟(CRISP)队列
Kidney Int. 2003 Sep;64(3):1035-45. doi: 10.1046/j.1523-1755.2003.00185.x.
5
Current diagnostic evaluation of autosomal dominant polycystic kidney disease.常染色体显性多囊肾病的当前诊断评估
Pol Arch Med Wewn. 2008 Dec;118(12):767-73.
6
Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.常染色体显性多囊肾病中肾血流的磁共振测量与疾病进展
Clin J Am Soc Nephrol. 2007 Jan;2(1):112-20. doi: 10.2215/CJN.00910306. Epub 2006 Nov 2.
7
Intermediate volume on computed tomography imaging defines a fibrotic compartment that predicts glomerular filtration rate decline in autosomal dominant polycystic kidney disease patients.CT 影像学中间容积定义了一个纤维化区域,该区域可预测常染色体显性遗传多囊肾病患者肾小球滤过率下降。
Am J Pathol. 2011 Aug;179(2):619-27. doi: 10.1016/j.ajpath.2011.04.036. Epub 2011 Jun 17.
8
Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease.长效生长抑素治疗常染色体显性遗传性多囊肾病的安全性和有效性。
Kidney Int. 2005 Jul;68(1):206-16. doi: 10.1111/j.1523-1755.2005.00395.x.
9
Reliability of Total Renal Volume Computation in Polycystic Kidney Disease From Magnetic Resonance Imaging.基于磁共振成像的多囊肾病总肾体积计算的可靠性
Acad Radiol. 2015 Nov;22(11):1376-84. doi: 10.1016/j.acra.2015.06.018. Epub 2015 Aug 12.
10
Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease.磁共振测量肾血流量作为常染色体显性多囊肾病疾病严重程度的标志物。
Kidney Int. 2003 Dec;64(6):2214-21. doi: 10.1046/j.1523-1755.2003.00326.x.

引用本文的文献

1
Reliability of radiomic analysis on multiparametric MRI for patients affected by autosomal dominant polycystic kidney disease.常染色体显性多囊肾病患者多参数磁共振成像的影像组学分析可靠性
Sci Rep. 2025 May 13;15(1):16526. doi: 10.1038/s41598-025-99982-x.
2
MicroRNA and renal fibrosis in autosomal dominant polycystic kidney disease: a longitudinal study.微小RNA与常染色体显性多囊肾病中的肾纤维化:一项纵向研究
J Nephrol. 2025 Jan;38(1):153-162. doi: 10.1007/s40620-024-01965-0. Epub 2024 Jul 5.
3
Evaluation of advanced imaging biomarkers at kidney failure in patients with ADPKD: a pilot study.
常染色体显性多囊肾病患者肾衰竭时的高级影像学生物标志物评估:一项试点研究。
Clin Kidney J. 2023 May 23;16(10):1691-1700. doi: 10.1093/ckj/sfad114. eCollection 2023 Oct.
4
Abdominal Imaging in ADPKD: Beyond Total Kidney Volume.常染色体显性多囊肾病的腹部影像学检查:超越总肾体积
J Clin Med. 2023 Aug 5;12(15):5133. doi: 10.3390/jcm12155133.
5
Diffusion magnetic resonance imaging for kidney cyst volume quantification and non-cystic tissue characterisation in ADPKD.磁共振弥散加权成像在多囊肾病中肾囊肿体积定量和非囊组织特征分析中的应用。
Eur Radiol. 2023 Sep;33(9):6009-6019. doi: 10.1007/s00330-023-09601-4. Epub 2023 Apr 5.
6
Utility of new image-derived biomarkers for autosomal dominant polycystic kidney disease prognosis using automated instance cyst segmentation.基于自动实例囊肿分割的新影像衍生生物标志物在常染色体显性多囊肾病预后中的应用。
Kidney Int. 2023 Aug;104(2):334-342. doi: 10.1016/j.kint.2023.01.010. Epub 2023 Feb 1.
7
The correlation between kidney volume and measured glomerular filtration rate in an Asian ADPKD population: a prospective cohort study.亚洲多囊肾病患者肾脏体积与肾小球滤过率测定值的相关性:一项前瞻性队列研究。
BMC Nephrol. 2021 May 15;22(1):178. doi: 10.1186/s12882-021-02392-0.
8
Methodological issues in clinical trials of polycystic kidney disease: a focused review.多囊肾病临床试验中的方法学问题:聚焦综述
J Nephrol. 2017 Jun;30(3):363-371. doi: 10.1007/s40620-016-0358-6. Epub 2016 Nov 17.
9
The importance of total kidney volume in evaluating progression of polycystic kidney disease.总肾体积在评估多囊肾病进展中的重要性。
Nat Rev Nephrol. 2016 Nov;12(11):667-677. doi: 10.1038/nrneph.2016.135. Epub 2016 Oct 3.
10
Suitability of Patients with Autosomal Dominant Polycystic Kidney Disease for Renal Transcatheter Arterial Embolization.常染色体显性遗传性多囊肾病患者接受肾动脉导管栓塞术的适用性
J Am Soc Nephrol. 2016 Jul;27(7):2177-87. doi: 10.1681/ASN.2015010067. Epub 2015 Nov 30.